Overview

Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors

Status:
Terminated

Trial end date:
2016-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to verify if adding a locoregional treatment of liver metastasis (with trans-arterial embolization-TAE) to medical treatments of proven efficacy can prolong the progression free survival of patients affected by neuroendocrine tumors (NET) with inoperable liver metastases

Phase:

Phase 3

Details

Lead Sponsor:

National Cancer Institute, Naples

Collaborators:

Federico II University
Second University of Naples
University of Campania "Luigi Vanvitelli"

Treatments:

Somatostatin